1. Home
  2. FTFT vs CVM Comparison

FTFT vs CVM Comparison

Compare FTFT & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Future FinTech Group Inc.

FTFT

Future FinTech Group Inc.

N/A

Current Price

$2.73

Market Cap

26.0M

ML Signal

N/A

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

N/A

Current Price

$1.38

Market Cap

30.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FTFT
CVM
Founded
N/A
1983
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
30.6M
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
FTFT
CVM
Price
$2.73
$1.38
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $12.50
AVG Volume (30 Days)
★ 806.4K
252.6K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $3,829,805.00
$264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 77.46
65.45
52 Week Low
$0.55
$0.89
52 Week High
$122.23
$7.80

Technical Indicators

Market Signals
Indicator
FTFT
CVM
Relative Strength Index (RSI) 48.53 35.99
Support Level $1.78 $1.34
Resistance Level $3.64 $1.52
Average True Range (ATR) 0.45 0.14
MACD 0.08 -0.04
Stochastic Oscillator 53.36 7.00

Price Performance

Historical Comparison
FTFT
CVM

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the production and sale of fruit juice concentrates (including fruit purees and fruit juices), fruit beverages (including fruit juice beverages and fruit cider beverages) in the PRC. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The Company classified its business segments into Trading Commission and Consulting services, Fast-Moving Consumer Goods (FMCG), and Supply Chain Financing and Trading.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: